BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Helmy A, Guilfoyle MR, Carpenter KL, Pickard JD, Menon DK, Hutchinson PJ. Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial. J Cereb Blood Flow Metab 2014;34:845-51. [PMID: 24569690 DOI: 10.1038/jcbfm.2014.23] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Bouras M, Asehnoune K, Roquilly A. Immune modulation after traumatic brain injury. Front Med 2022;9. [DOI: 10.3389/fmed.2022.995044] [Reference Citation Analysis]
2 Kalpachidou T, Riehl L, Schöpf CL, Ucar B, Kress M. Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain. PAIN 2022;163:S79-S98. [DOI: 10.1097/j.pain.0000000000002737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 van Erp IAM, Michailidou I, van Essen TA, van der Jagt M, Moojen W, Peul WC, Baas F, Fluiter K. Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury. Neurotherapeutics 2022. [PMID: 36222978 DOI: 10.1007/s13311-022-01306-8] [Reference Citation Analysis]
4 Jacquens A, Needham EJ, Zanier ER, Degos V, Gressens P, Menon D. Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side. IJMS 2022;23:11193. [DOI: 10.3390/ijms231911193] [Reference Citation Analysis]
5 Fomicheva EE, Shanin SN, Filatenkova TA, Novikova NS, Dyatlova AS, Ishchenko AM, Serebryanaya NB. Correction of Behavioral Disorders and State of Microglia with Recombinant IL-1 Receptor Antagonist in Experimental Traumatic Brain Injury. J Evol Biochem Phys 2022;58:1571-1582. [DOI: 10.1134/s0022093022050258] [Reference Citation Analysis]
6 Simats A, Liesz A. Systemic inflammation after stroke: implications for post-stroke comorbidities. EMBO Mol Med 2022;:e16269. [PMID: 35971650 DOI: 10.15252/emmm.202216269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ooi SZY, Spencer RJ, Hodgson M, Mehta S, Phillips NL, Preest G, Manivannan S, Wise MP, Galea J, Zaben M. Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review. Neurosurg Rev 2022. [PMID: 35790656 DOI: 10.1007/s10143-022-01827-y] [Reference Citation Analysis]
8 Kumar G, Asthana P, Yung WH, Kwan KM, Tin C, Ma CHE. Deep Brain Stimulation of the Interposed Nucleus Reverses Motor Deficits and Stimulates Production of Anti-inflammatory Cytokines in Ataxia Mice. Mol Neurobiol 2022. [PMID: 35581519 DOI: 10.1007/s12035-022-02872-w] [Reference Citation Analysis]
9 Custers M, Nestor L, De Bundel D, Van Eeckhaut A, Smolders I. Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid. Pharmaceutics 2022;14:1051. [DOI: 10.3390/pharmaceutics14051051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shchokina K, Ulanova V, Drogovoz S. Cerebroprotective properties of recombinant interleukin-1 receptor – an experimental study. CSF 2022;71:34-40. [DOI: 10.5817/csf2022-1-34] [Reference Citation Analysis]
11 Elcivan M, Kowark A, Coburn M, Hamou HA, Kremer B, Clusmann H, Höllig A. A Retrospective Analysis of Randomized Controlled Trials on Traumatic Brain Injury: Evaluation of CONSORT Item Adherence. Brain Sci 2021;11:1504. [PMID: 34827503 DOI: 10.3390/brainsci11111504] [Reference Citation Analysis]
12 Sjöström EO, Culot M, Leickt L, Åstrand M, Nordling E, Gosselet F, Kaiser C. Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier. Brain Behav Immun Health 2021;16:100307. [PMID: 34589799 DOI: 10.1016/j.bbih.2021.100307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Lassarén P, Lindblad C, Frostell A, Carpenter KLH, Guilfoyle MR, Hutchinson PJA, Helmy A, Thelin EP. Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury. J Neuroinflammation 2021;18:221. [PMID: 34563211 DOI: 10.1186/s12974-021-02264-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
14 Huang X, You W, Zhu Y, Xu K, Yang X, Wen L. Microglia: A Potential Drug Target for Traumatic Axonal Injury. Neural Plast 2021;2021:5554824. [PMID: 34093701 DOI: 10.1155/2021/5554824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Seo JH, Dalal MS, Contreras JE. Pannexin-1 Channels as Mediators of Neuroinflammation. Int J Mol Sci 2021;22:5189. [PMID: 34068881 DOI: 10.3390/ijms22105189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
16 Bourgeois-Tardif S, De Beaumont L, Rivera JC, Chemtob S, Weil AG. Role of innate inflammation in traumatic brain injury. Neurol Sci 2021;42:1287-99. [PMID: 33464411 DOI: 10.1007/s10072-020-05002-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Koh S, Wirrell E, Vezzani A, Nabbout R, Muscal E, Kaliakatsos M, Wickström R, Riviello JJ, Brunklaus A, Payne E, Valentin A, Wells E, Carpenter JL, Lee K, Lai YC, Eschbach K, Press CA, Gorman M, Stredny CM, Roche W, Mangum T. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. Epilepsia Open 2021;6:62-72. [PMID: 33681649 DOI: 10.1002/epi4.12447] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
18 Yates AG, Jogia T, Gillespie ER, Couch Y, Ruitenberg MJ, Anthony DC. Acute IL-1RA treatment suppresses the peripheral and central inflammatory response to spinal cord injury. J Neuroinflammation 2021;18:15. [PMID: 33407641 DOI: 10.1186/s12974-020-02050-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
19 Farooqui AA. Molecular aspects of regeneration and neuroprotection in neurotraumatic diseases. Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders 2021. [DOI: 10.1016/b978-0-12-821711-5.00006-1] [Reference Citation Analysis]
20 Montivero AJ, Ghersi MS, Catalán-figueroa J, Formica ML, Camacho N, Culasso AF, Hereñú CB, Palma SD, Pérez MF. Beyond Acute Traumatic Brain Injury: Molecular Implications of Associated Neuroinflammation in Higher-Order Cognitive Processes. Psychiatry and Neuroscience Update 2021. [DOI: 10.1007/978-3-030-61721-9_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Alam A, Thelin EP, Tajsic T, Khan DZ, Khellaf A, Patani R, Helmy A. Cellular infiltration in traumatic brain injury. J Neuroinflammation 2020;17:328. [PMID: 33143727 DOI: 10.1186/s12974-020-02005-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 22.5] [Reference Citation Analysis]
22 Klein P, Friedman A, Hameed MQ, Kaminski RM, Bar-Klein G, Klitgaard H, Koepp M, Jozwiak S, Prince DA, Rotenberg A, Twyman R, Vezzani A, Wong M, Löscher W. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? Epilepsia 2020;61:359-86. [PMID: 32196665 DOI: 10.1111/epi.16450] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
23 Jarrahi A, Braun M, Ahluwalia M, Gupta RV, Wilson M, Munie S, Ahluwalia P, Vender JR, Vale FL, Dhandapani KM, Vaibhav K. Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions. Biomedicines 2020;8:E389. [PMID: 33003373 DOI: 10.3390/biomedicines8100389] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 24.0] [Reference Citation Analysis]
24 Murata Y, Sugimoto K, Yang C, Harada K, Gono R, Harada T, Miyashita Y, Higashisaka K, Katada R, Tanaka J, Matsumoto H. Activated microglia-derived macrophage-like cells exacerbate brain edema after ischemic stroke correlate with astrocytic expression of aquaporin-4 and interleukin-1 alpha release. Neurochem Int 2020;140:104848. [PMID: 32920036 DOI: 10.1016/j.neuint.2020.104848] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
25 Irrera N, Russo M, Pallio G, Bitto A, Mannino F, Minutoli L, Altavilla D, Squadrito F. The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury. Int J Mol Sci 2020;21:E6204. [PMID: 32867310 DOI: 10.3390/ijms21176204] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
26 Tweedie D, Karnati HK, Mullins R, Pick CG, Hoffer BJ, Goetzl EJ, Kapogiannis D, Greig NH. Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury. Elife 2020;9:e55827. [PMID: 32804078 DOI: 10.7554/eLife.55827] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
27 Baker TL, Sun M, Semple BD, Tyebji S, Tonkin CJ, Mychasiuk R, Shultz SR. Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury? J Neuroinflammation 2020;17:222. [PMID: 32711529 DOI: 10.1186/s12974-020-01885-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Brett BL, Savitz J, Nitta M, España L, Teague TK, Nelson LD, McCrea MA, Meier TB. Systemic inflammation moderates the association of prior concussion with hippocampal volume and episodic memory in high school and collegiate athletes. Brain Behav Immun 2020;89:380-8. [PMID: 32717401 DOI: 10.1016/j.bbi.2020.07.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ruppert KA, Prabhakara KS, Toledano-Furman NE, Udtha S, Arceneaux AQ, Park H, Dao A, Cox CS, Olson SD. Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI. PLoS One 2020;15:e0233263. [PMID: 32453741 DOI: 10.1371/journal.pone.0233263] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
30 Evans LP, Woll AW, Wu S, Todd BP, Hehr N, Hedberg-Buenz A, Anderson MG, Newell EA, Ferguson PJ, Mahajan VB, Harper MM, Bassuk AG. Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes. J Neurotrauma 2020;37:1463-80. [PMID: 32056479 DOI: 10.1089/neu.2019.6725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
31 Parker H, Ellison SM, Holley RJ, O'Leary C, Liao A, Asadi J, Glover E, Ghosh A, Jones S, Wilkinson FL, Brough D, Pinteaux E, Boutin H, Bigger BW. Haematopoietic stem cell gene therapy with IL-1Ra rescues cognitive loss in mucopolysaccharidosis IIIA. EMBO Mol Med 2020;12:e11185. [PMID: 32057196 DOI: 10.15252/emmm.201911185] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
32 Hübner M, Effinger D, Wu T, Strauß G, Pogoda K, Kreth FW, Kreth S. The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation. Cancers (Basel) 2020;12:E433. [PMID: 32069807 DOI: 10.3390/cancers12020433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
33 Thome JG, Reeder EL, Collins SM, Gopalan P, Robson MJ. Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury. Front Behav Neurosci 2019;13:287. [PMID: 32038189 DOI: 10.3389/fnbeh.2019.00287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
34 Casault C, Al Sultan AS, Banoei M, Couillard P, Kramer A, Winston BW. Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire? Neurocrit Care 2019;30:22-32. [PMID: 29569129 DOI: 10.1007/s12028-018-0522-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
35 Ozen I, Ruscher K, Nilsson R, Flygt J, Clausen F, Marklund N. Interleukin-1 Beta Neutralization Attenuates Traumatic Brain Injury-Induced Microglia Activation and Neuronal Changes in the Globus Pallidus. Int J Mol Sci 2020;21:E387. [PMID: 31936248 DOI: 10.3390/ijms21020387] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
36 Marklund N. Pharmacological Neuroprotection. Management of Severe Traumatic Brain Injury 2020. [DOI: 10.1007/978-3-030-39383-0_56] [Reference Citation Analysis]
37 Enblad P, Howells T, Hillered L. Neurointensive Care Unit as a Platform for Advanced Clinical Research. Management of Severe Traumatic Brain Injury 2020. [DOI: 10.1007/978-3-030-39383-0_87] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Perrault DP, Bramos A, Xu X, Shi S, Wong AK. Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing. Ann Plast Surg 2018;80:S317-21. [PMID: 29553981 DOI: 10.1097/SAP.0000000000001417] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
39 Khellaf A, Khan DZ, Helmy A. Recent advances in traumatic brain injury. J Neurol 2019;266:2878-89. [PMID: 31563989 DOI: 10.1007/s00415-019-09541-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 89] [Article Influence: 26.0] [Reference Citation Analysis]
40 Thelin EP, Hall CE, Tyzack GE, Frostell A, Giorgi-Coll S, Alam A, Carpenter KLH, Mitchell J, Tajsic T, Hutchinson PJ, Patani R, Helmy A. Delineating Astrocytic Cytokine Responses in a Human Stem Cell Model of Neural Trauma. J Neurotrauma 2020;37:93-105. [PMID: 31452443 DOI: 10.1089/neu.2019.6480] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
41 McKinley TO, Lei Z, Kalbas Y, White FA, Shi Z, Wu F, Xu ZC, Rodgers RB. Blood purification by nonselective hemoadsorption prevents death after traumatic brain injury and hemorrhagic shock in rats. J Trauma Acute Care Surg 2018;85:1063-71. [PMID: 30211852 DOI: 10.1097/TA.0000000000002069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Chen Y, Meng J, Bi F, Li H, Chang C, Ji C, Liu W. EK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury. Front Mol Neurosci 2019;12:202. [PMID: 31555089 DOI: 10.3389/fnmol.2019.00202] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
43 Nitta ME, Savitz J, Nelson LD, Teague TK, Hoelzle JB, McCrea MA, Meier TB. Acute elevation of serum inflammatory markers predicts symptom recovery after concussion. Neurology 2019;93:e497-507. [PMID: 31270219 DOI: 10.1212/WNL.0000000000007864] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
44 Needham E, Helmy A, Zanier E, Jones J, Coles A, Menon D. The immunological response to traumatic brain injury. Journal of Neuroimmunology 2019;332:112-25. [DOI: 10.1016/j.jneuroim.2019.04.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 19.3] [Reference Citation Analysis]
45 Zeiler FA, McFadyen C, Newcombe VFJ, Synnot A, Donoghue EL, Ripatti S, Steyerberg EW, Gruen RL, McAllister TW, Rosand J, Palotie A, Maas AIR, Menon DK. Genetic Influences on Patient-Oriented Outcomes in Traumatic Brain Injury: A Living Systematic Review of Non-Apolipoprotein E Single-Nucleotide Polymorphisms. J Neurotrauma 2021;38:1107-23. [PMID: 29799308 DOI: 10.1089/neu.2017.5583] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
46 Evans LP, Woll AW, Wu S, Todd BP, Hehr N, Hedberg-buenz A, Anderson MG, Newell EA, Ferguson PJ, Mahajan VB, Harper MM, Bassuk AG. Modulation of post-traumatic immune response using anti-IL-1 therapy for improved visual outcomes: Anti-IL-1 improves post-traumatic visual outcomes.. [DOI: 10.1101/659581] [Reference Citation Analysis]
47 Morganti-Kossmann MC, Semple BD, Hellewell SC, Bye N, Ziebell JM. The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments. Acta Neuropathol 2019;137:731-55. [PMID: 30535946 DOI: 10.1007/s00401-018-1944-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 29.7] [Reference Citation Analysis]
48 Huang AJ, Kornguth D, Kornguth S. Cognitive Decline Secondary to Therapeutic Brain Radiation-Similarities and Differences to Traumatic Brain Injury. Brain Sci 2019;9:E97. [PMID: 31035608 DOI: 10.3390/brainsci9050097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Yue Y, Shang C, Dong H, Meng K. Interleukin-1 in cerebrospinal fluid for evaluating the neurological outcome in traumatic brain injury. Biosci Rep 2019;39:BSR20181966. [PMID: 30898979 DOI: 10.1042/BSR20181966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Killen MJ, Giorgi-Coll S, Helmy A, Hutchinson PJ, Carpenter KL. Metabolism and inflammation: implications for traumatic brain injury therapeutics. Expert Rev Neurother 2019;19:227-42. [PMID: 30848963 DOI: 10.1080/14737175.2019.1582332] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
51 Kassi AAY, Mahavadi AK, Clavijo A, Caliz D, Lee SW, Ahmed AI, Yokobori S, Hu Z, Spurlock MS, Wasserman JM, Rivera KN, Nodal S, Powell HR, Di L, Torres R, Leung LY, Rubiano AM, Bullock RM, Gajavelli S. Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI. Front Neurol 2018;9:1097. [PMID: 30719019 DOI: 10.3389/fneur.2018.01097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
52 Yang Y, Ye Y, Kong C, Su X, Zhang X, Bai W, He X. MiR-124 Enriched Exosomes Promoted the M2 Polarization of Microglia and Enhanced Hippocampus Neurogenesis After Traumatic Brain Injury by Inhibiting TLR4 Pathway. Neurochem Res 2019;44:811-28. [DOI: 10.1007/s11064-018-02714-z] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 27.0] [Reference Citation Analysis]
53 Dinarello CA. Interleukin-1 Mediated Autoinflammation from Heart Disease to Cancer. Textbook of Autoinflammation 2019. [DOI: 10.1007/978-3-319-98605-0_39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Khellaf A, Khan DZ, Helmy A. Recent advances in traumatic brain injury. J Neurol 2019;266:2878-89. [PMID: 31563989 DOI: 10.1007/s00415-019-09541-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Beckwith N, Helfgott S. Neurologic and Psychiatric Effects of Cytokines and Targeted Biological Therapies. Neurorheumatology 2019. [DOI: 10.1007/978-3-030-16928-2_29] [Reference Citation Analysis]
56 Cavalli G, Dinarello CA. Anakinra Therapy for Non-cancer Inflammatory Diseases. Front Pharmacol 2018;9:1157. [PMID: 30459597 DOI: 10.3389/fphar.2018.01157] [Cited by in Crossref: 152] [Cited by in F6Publishing: 158] [Article Influence: 38.0] [Reference Citation Analysis]
57 Wagner AK, Kumar RG. TBI Rehabilomics Research: Conceptualizing a humoral triad for designing effective rehabilitation interventions. Neuropharmacology 2019;145:133-44. [PMID: 30222984 DOI: 10.1016/j.neuropharm.2018.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
58 Clausen F, Marklund N, Hillered L. Acute Inflammatory Biomarker Responses to Diffuse Traumatic Brain Injury in the Rat Monitored by a Novel Microdialysis Technique. J Neurotrauma 2019;36:201-11. [PMID: 29790398 DOI: 10.1089/neu.2018.5636] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
59 Chung JY, Krapp N, Wu L, Lule S, McAllister LM, Edmiston WJ 3rd, Martin S, Levy E, Songtachalert T, Sherwood JS, Buckley EM, Sanders B, Izzy S, Hickman S, Guo S, Lok J, El Khoury J, Lo EH, Kaplan D, Whalen MJ. Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice. J Neurotrauma 2019;36:370-9. [PMID: 29768967 DOI: 10.1089/neu.2018.5659] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
60 Carpenter KL, Young AM, Hutchinson PJ. Advanced monitoring in traumatic brain injury: microdialysis. Curr Opin Crit Care 2017;23:103-9. [PMID: 28207601 DOI: 10.1097/MCC.0000000000000400] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
61 Wallisch JS, Simon DW, Bayır H, Bell MJ, Kochanek PM, Clark RSB. Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children. Neurocrit Care 2017;27:44-50. [PMID: 28181102 DOI: 10.1007/s12028-017-0378-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 15.8] [Reference Citation Analysis]
62 Newell EA, Todd BP, Mahoney J, Pieper AA, Ferguson PJ, Bassuk AG. Combined Blockade of Interleukin-1α and -1β Signaling Protects Mice from Cognitive Dysfunction after Traumatic Brain Injury. eNeuro 2018;5:ENEURO. [PMID: 29662944 DOI: 10.1523/ENEURO.0385-17.2018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
63 Dinarello CA. Treatment of Inflammatory Diseases with IL-1 Blockade. Curr Otorhinolaryngol Rep 2018;6:1-14. [PMID: 33133777 DOI: 10.1007/s40136-018-0181-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
64 Lahiani A, Brand-Yavin A, Yavin E, Lazarovici P. Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells. Brain Sci 2018;8:E32. [PMID: 29419806 DOI: 10.3390/brainsci8020032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
65 Liu X, Quan N. Microglia and CNS Interleukin-1: Beyond Immunological Concepts. Front Neurol 2018;9:8. [PMID: 29410649 DOI: 10.3389/fneur.2018.00008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 20.5] [Reference Citation Analysis]
66 Zhang DD, Jin C, Zhang YT, Gan XD, Zou MJ, Wang YY, Fu WL, Xu T, Xing WW, Xia WR, Xu DG. A novel IL-1RA-PEP fusion protein alleviates blood-brain barrier disruption after ischemia-reperfusion in male rats. J Neuroinflammation 2018;15:16. [PMID: 29334965 DOI: 10.1186/s12974-018-1058-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
67 Farooqui AA. Potential Neuroprotective Strategies for Traumatic Brain Injury. Ischemic and Traumatic Brain and Spinal Cord Injuries 2018. [DOI: 10.1016/b978-0-12-813596-9.00007-9] [Reference Citation Analysis]
68 Helbok R, Beer R. Cerebrospinal fluid and brain extracellular fluid in severe brain trauma. Cerebrospinal Fluid in Neurologic Disorders. Elsevier; 2018. pp. 237-58. [DOI: 10.1016/b978-0-12-804279-3.00014-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
69 Liu C, Yang J, Zhang C, Liu M, Geng X, Ji X, Du H, Zhao H. Analysis of long non-coding RNA expression profiles following focal cerebral ischemia in mice. Neurosci Lett 2018;665:123-9. [PMID: 29195908 DOI: 10.1016/j.neulet.2017.11.058] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
70 Tsitsopoulos PP, Abu Hamdeh S, Marklund N. Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury. Front Neurol 2017;8:599. [PMID: 29209266 DOI: 10.3389/fneur.2017.00599] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
71 Carteron L, Bouzat P, Oddo M. Cerebral Microdialysis Monitoring to Improve Individualized Neurointensive Care Therapy: An Update of Recent Clinical Data. Front Neurol 2017;8:601. [PMID: 29180981 DOI: 10.3389/fneur.2017.00601] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
72 Thelin EP, Hall CE, Gupta K, Carpenter KLH, Chandran S, Hutchinson PJ, Patani R, Helmy A. Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model. J Neurotrauma 2018;35:341-52. [PMID: 28978285 DOI: 10.1089/neu.2017.5155] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
73 Sun M, Brady RD, Wright DK, Kim HA, Zhang SR, Sobey CG, Johnstone MR, O'brien TJ, Semple BD, Mcdonald SJ, Shultz SR. Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma. Brain, Behavior, and Immunity 2017;66:359-71. [DOI: 10.1016/j.bbi.2017.08.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
74 Mamik MK, Power C. Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain 2017;140:2273-85. [PMID: 29050380 DOI: 10.1093/brain/awx133] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 18.0] [Reference Citation Analysis]
75 Rodriguez-Grande B, Ichkova A, Lemarchant S, Badaut J. Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development. AAPS J 2017;19:1615-25. [PMID: 28905273 DOI: 10.1208/s12248-017-0123-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
76 Ercole A, Magnoni S, Vegliante G, Pastorelli R, Surmacki J, Bohndiek SE, Zanier ER. Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury. Front Neurol 2017;8:450. [PMID: 28912750 DOI: 10.3389/fneur.2017.00450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
77 Irvine K, Clark JD. Chronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms. Pain Medicine 2018;19:1315-33. [DOI: 10.1093/pm/pnx153] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
78 Dugue R, Nath M, Dugue A, Barone FC. Roles of Pro- and Anti-inflammatory Cytokines in Traumatic Brain Injury and Acute Ischemic Stroke. Mechanisms of Neuroinflammation 2017. [DOI: 10.5772/intechopen.70099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
79 Thelin EP, Tajsic T, Zeiler FA, Menon DK, Hutchinson PJA, Carpenter KLH, Morganti-Kossmann MC, Helmy A. Monitoring the Neuroinflammatory Response Following Acute Brain Injury. Front Neurol 2017;8:351. [PMID: 28775710 DOI: 10.3389/fneur.2017.00351] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 14.4] [Reference Citation Analysis]
80 Semple BD, O'Brien TJ, Gimlin K, Wright DK, Kim SE, Casillas-Espinosa PM, Webster KM, Petrou S, Noble-Haeusslein LJ. Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain. J Neurosci 2017;37:7864-77. [PMID: 28724747 DOI: 10.1523/JNEUROSCI.0982-17.2017] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 13.8] [Reference Citation Analysis]
81 Zeiler FA, Thelin EP, Czosnyka M, Hutchinson PJ, Menon DK, Helmy A. Cerebrospinal Fluid and Microdialysis Cytokines in Severe Traumatic Brain Injury: A Scoping Systematic Review. Front Neurol 2017;8:331. [PMID: 28740480 DOI: 10.3389/fneur.2017.00331] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
82 Zhang DD, Zou MJ, Zhang YT, Fu WL, Xu T, Wang JX, Xia WR, Huang ZG, Gan XD, Zhu XM, Xu DG. A novel IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation. Exp Neurol 2017;297:1-13. [PMID: 28602833 DOI: 10.1016/j.expneurol.2017.06.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
83 Galea J, Ogungbenro K, Hulme S, Patel H, Scarth S, Hoadley M, Illingworth K, McMahon CJ, Tzerakis N, King AT, Vail A, Hopkins SJ, Rothwell N, Tyrrell P. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg 2018;128:515-23. [PMID: 28298024 DOI: 10.3171/2016.9.JNS16615] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
84 Simon DW, McGeachy MJ, Bayır H, Clark RS, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol 2017;13:171-91. [PMID: 28186177 DOI: 10.1038/nrneurol.2017.13] [Cited by in Crossref: 402] [Cited by in F6Publishing: 423] [Article Influence: 80.4] [Reference Citation Analysis]
85 Xu H, Wang Z, Li J, Wu H, Peng Y, Fan L, Chen J, Gu C, Yan F, Wang L, Chen G. The Polarization States of Microglia in TBI: A New Paradigm for Pharmacological Intervention. Neural Plast 2017;2017:5405104. [PMID: 28255460 DOI: 10.1155/2017/5405104] [Cited by in Crossref: 55] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
86 Webster KM, Sun M, Crack P, O'Brien TJ, Shultz SR, Semple BD. Inflammation in epileptogenesis after traumatic brain injury. J Neuroinflammation 2017;14:10. [PMID: 28086980 DOI: 10.1186/s12974-016-0786-1] [Cited by in Crossref: 144] [Cited by in F6Publishing: 151] [Article Influence: 28.8] [Reference Citation Analysis]
87 Thelin EP, Carpenter KL, Hutchinson PJ, Helmy A. Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development. AAPS J 2017;19:367-76. [PMID: 28070712 DOI: 10.1208/s12248-016-0027-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
88 McKee CA, Lukens JR. Emerging Roles for the Immune System in Traumatic Brain Injury. Front Immunol 2016;7:556. [PMID: 27994591 DOI: 10.3389/fimmu.2016.00556] [Cited by in Crossref: 134] [Cited by in F6Publishing: 144] [Article Influence: 22.3] [Reference Citation Analysis]
89 Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H. Traumatic brain injuries. Nat Rev Dis Primers 2016;2:16084. [PMID: 27853132 DOI: 10.1038/nrdp.2016.84] [Cited by in Crossref: 262] [Cited by in F6Publishing: 275] [Article Influence: 43.7] [Reference Citation Analysis]
90 Jadhav SB, Khaowroongrueng V, Derendorf H. Microdialysis of Large Molecules. Journal of Pharmaceutical Sciences 2016;105:3233-42. [DOI: 10.1016/j.xphs.2016.08.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
91 Diamond EL, Abdel-Wahab O, Durham BH, Dogan A, Ozkaya N, Brody L, Arcila M, Bowers C, Fluchel M. Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease. Blood 2016;128:1896-8. [PMID: 27535996 DOI: 10.1182/blood-2016-06-725143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
92 Chakraborty S, Skolnick B, Narayan RK. Neuroprotection Trials in Traumatic Brain Injury. Curr Neurol Neurosci Rep 2016;16:29. [PMID: 26883431 DOI: 10.1007/s11910-016-0625-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
93 Lénárt N, Brough D, Dénes Á. Inflammasomes link vascular disease with neuroinflammation and brain disorders. J Cereb Blood Flow Metab 2016;36:1668-85. [PMID: 27486046 DOI: 10.1177/0271678X16662043] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 16.7] [Reference Citation Analysis]
94 Mazzeo AT, Filippini C, Rosato R, Fanelli V, Assenzio B, Piper I, Howells T, Mastromauro I, Berardino M, Ducati A, Mascia L. Multivariate projection method to investigate inflammation associated with secondary insults and outcome after human traumatic brain injury: a pilot study. J Neuroinflammation 2016;13:157. [PMID: 27324502 DOI: 10.1186/s12974-016-0624-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
95 Sordillo PP, Sordillo LA, Helson L. Bifunctional role of pro-inflammatory cytokines after traumatic brain injury. Brain Injury 2016;30:1043-53. [DOI: 10.3109/02699052.2016.1163618] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
96 Hill CS, Coleman MP, Menon DK. Traumatic Axonal Injury: Mechanisms and Translational Opportunities. Trends Neurosci 2016;39:311-24. [PMID: 27040729 DOI: 10.1016/j.tins.2016.03.002] [Cited by in Crossref: 183] [Cited by in F6Publishing: 191] [Article Influence: 30.5] [Reference Citation Analysis]
97 Ekmark-Lewén S, Flygt J, Fridgeirsdottir GA, Kiwanuka O, Hånell A, Meyerson BJ, Mir AK, Gram H, Lewén A, Clausen F, Hillered L, Marklund N. Diffuse traumatic axonal injury in mice induces complex behavioural alterations that are normalized by neutralization of interleukin-1β. Eur J Neurosci 2016;43:1016-33. [PMID: 27091435 DOI: 10.1111/ejn.13190] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
98 Ma J, Wang J, Cheng J, Xiao W, Fan K, Gu J, Yu B, Yin G, Wu J, Ren J, Hou J, Jiang Y, Tan Y, Jin W. Impacts of Blast-Induced Traumatic Brain Injury on Expressions of Hepatic Cytochrome P450 1A2, 2B1, 2D1, and 3A2 in Rats. Cell Mol Neurobiol 2017;37:111-20. [PMID: 26913515 DOI: 10.1007/s10571-016-0351-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
99 Dugue R, Barone FC. Ischemic, traumatic and neurodegenerative brain inflammatory changes. Future Neurology 2016;11:77-96. [DOI: 10.2217/fnl.16.5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
100 Aertker BM, Bedi S, Cox CS. Strategies for CNS repair following TBI. Experimental Neurology 2016;275:411-26. [DOI: 10.1016/j.expneurol.2015.01.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
101 Stahel PF, Flierl MA. Head Injuries: Neurosurgical and Orthopedic Strategies. The Poly-Traumatized Patient with Fractures 2016. [DOI: 10.1007/978-3-662-47212-5_6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Hellewell S, Semple BD, Morganti-Kossmann MC. Therapies negating neuroinflammation after brain trauma. Brain Res 2016;1640:36-56. [PMID: 26740405 DOI: 10.1016/j.brainres.2015.12.024] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 9.1] [Reference Citation Analysis]
103 Neumann S, Shields NJ, Balle T, Chebib M, Clarkson AN. Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective. Int J Mol Sci 2015;16:29029-46. [PMID: 26690125 DOI: 10.3390/ijms161226141] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
104 Helmy A, Guilfoyle MR, Carpenter KLH, Pickard JD, Menon DK, Hutchinson PJ. Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury. J Cereb Blood Flow Metab 2016;36:1434-48. [PMID: 26661249 DOI: 10.1177/0271678X15620204] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
105 Zhang H, Maqsudi S, Rainczuk A, Duffield N, Lawrence J, Keane FM, Justa-Schuch D, Geiss-Friedlander R, Gorrell MD, Stephens AN. Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis. FEBS J. 2015;282:3737-3757. [PMID: 26175140 DOI: 10.1111/febs.13371] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
106 Perez-Polo JR, Rea HC, Johnson KM, Parsley MA, Unabia GC, Xu GY, Prough D, DeWitt DS, Paulucci-Holthauzen AA, Werrbach-Perez K, Hulsebosch CE. Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury. J Neurosci Res 2016;94:27-38. [PMID: 26172557 DOI: 10.1002/jnr.23617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
107 Bergold PJ. Treatment of traumatic brain injury with anti-inflammatory drugs. Exp Neurol 2016;275 Pt 3:367-80. [PMID: 26112314 DOI: 10.1016/j.expneurol.2015.05.024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 12.9] [Reference Citation Analysis]
108 Graber DJ, Costine BA, Hickey WF. Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets. J Neuroinflammation 2015;12:76. [PMID: 25895671 DOI: 10.1186/s12974-015-0298-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
109 Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg 2015;78:184-91. [PMID: 25539220 DOI: 10.1097/TA.0000000000000468] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 16.4] [Reference Citation Analysis]
110 Xiong Y, Zhang Y, Mahmood A, Chopp M. Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs 2015;24:743-60. [PMID: 25727893 DOI: 10.1517/13543784.2015.1021919] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
111 Kochanek PM, Jackson TC, Ferguson NM, Carlson SW, Simon DW, Brockman EC, Ji J, Bayır H, Poloyac SM, Wagner AK, Kline AE, Empey PE, Clark RS, Jackson EK, Dixon CE. Emerging therapies in traumatic brain injury. Semin Neurol 2015;35:83-100. [PMID: 25714870 DOI: 10.1055/s-0035-1544237] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
112 Helmy A, Carpenter KL, Hutchinson PJ. Comment on: 'Pitfalls in microdialysis methodology: an in vitro analysis of temperature, pressure and catheter use'. Physiol Meas 2015;36:621-2. [PMID: 25700129 DOI: 10.1088/0967-3334/36/3/621] [Reference Citation Analysis]
113 Galea JP, Tyrrell PJ, Patel HP, Vail A, King AT, Hopkins SJ. Reply to Comment on 'Pitfalls in microdialysis methodology: an in vitro analysis of temperature, pressure and catheter use'. Physiol Meas 2015;36:623-4. [PMID: 25700218 DOI: 10.1088/0967-3334/36/3/623] [Reference Citation Analysis]
114 Murray KN, Parry-Jones AR, Allan SM. Interleukin-1 and acute brain injury. Front Cell Neurosci 2015;9:18. [PMID: 25705177 DOI: 10.3389/fncel.2015.00018] [Cited by in Crossref: 96] [Cited by in F6Publishing: 104] [Article Influence: 13.7] [Reference Citation Analysis]
115 Dinarello CA. An expanding role for interleukin-1 blockade from gout to cancer. Mol Med 2014;20 Suppl 1:S43-58. [PMID: 25549233 DOI: 10.2119/molmed.2014.00232] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 8.5] [Reference Citation Analysis]
116 Needham E, Zandi MS. Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer’s disease, traumatic brain injury and schizophrenia. J Neurol 2014;261:2037-42. [DOI: 10.1007/s00415-014-7473-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
117 Balu R. Inflammation and Immune System Activation After Traumatic Brain Injury. Curr Neurol Neurosci Rep 2014;14. [DOI: 10.1007/s11910-014-0484-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]